Subcutaneous regular insulin for the treatment of diabetic ketoacidosis in children

被引:21
作者
Cohen, Michal [1 ,2 ]
Leibovitz, Noa [3 ]
Shilo, Smadar [1 ,2 ]
Zuckerman-Levin, Nehama [1 ,2 ,3 ]
Shavit, Itai [1 ,2 ,3 ]
Shehadeh, Naim [1 ,2 ,3 ]
机构
[1] Ruth Rappaport Childrens Hosp Haifa, Pediat Diabet Unit, Rambam Healthcare Campus, Haifa, Israel
[2] Ruth Rappaport Childrens Hosp Haifa, Pediat Div A, Rambam Healthcare Campus, Haifa, Israel
[3] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Haifa, Israel
关键词
diabetic ketoacidosis; pediatrics; subcutaneous insulin; type; 1; diabetes; PEDIATRIC-PATIENTS; CEREBRAL EDEMA; MANAGEMENT; TRENDS; DIAGNOSIS; LISPRO; YOUTH;
D O I
10.1111/pedi.12380
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Cohen M, Leibovitz N, Shilo S, Zuckerman-Levin N, Shavit I, Shehadeh N. Subcutaneous regular insulin for the treatment of diabetic ketoacidosis in children. Pediatric Diabetes 2017: 18: 290-296. Background: Diabetic ketoacidosis (DKA) treatment protocols vary, however low-dose intravenous administration of regular insulin is the standard care for replacing insulin in most centers. Few studies, the majority in adults, demonstrated subcutaneous injection of rapid-acting insulin every 1-2 hours to be a valid alternative. Objective: To evaluate the efficacy and safety of subcutaneous regular insulin administered every 4 hours in pediatric DKA in a clinical setting. Methods: A retrospective chart review was conducted. Charts of all children treated with subcutaneous regular insulin for DKA and pH >= 7.0, between 2007 and 2010, were reviewed. Seventy-six DKA episodes in 52 patients were included. Data regarding clinical characteristics, response to treatment, and the occurrence of complications were analyzed. DKA episodes in patients with new-onset diabetes and in those with established diabetes were compared. Results: Mean age was 11.6 +/- 4.0 yr. Eighteen episodes occurred in children with new-onset diabetes. In all episodes, our protocol resulted in recovery from DKA. Median time to DKA resolution (pH > 7.30, HCO3 > 15) was 10.3 (5.5, 14.2) h. The median total insulin dose was 0.05 (0.04, 0.06) (unit/kg/h). During DKA treatment, hypoglycemia occurred in one episode and hypokalemia, mostly mild, was documented in 14. No cardiac arrhythmias, incidents of cerebral edema, or mortality occurred. Conclusion: Subcutaneous regular insulin administered every 4 hours is an effective and safe alternative for the insulin treatment of DKA with pH > 7.0 in children. Such treatment has the potential to simplify insulin administration when compared to either intravenous regular insulin or q1-2 hour subcutaneous rapid insulin and reduce both patient inconvenience and admission costs.
引用
收藏
页码:290 / 296
页数:7
相关论文
共 23 条
[1]
Balluffi Andrew, 2004, Pediatr Crit Care Med, V5, P547, DOI 10.1097/01.PCC.0000137354.19807.44
[2]
Current Variability of Clinical Practice Management of Pediatric Diabetic Ketoacidosis in Illinois Pediatric Emergency Departments [J].
Barrios, Ellen K. ;
Hageman, Joseph ;
Lyons, Evelyn ;
Janies, Kathryn ;
Leonard, Daniel ;
Duck, Stephen ;
Fuchs, Susan .
PEDIATRIC EMERGENCY CARE, 2012, 28 (12) :1307-1313
[3]
Trends in the incidence of type 1 diabetes among Jews and Arabs in Israel [J].
Blumenfeld, Orit ;
Dichtiar, Rita ;
Shohat, Tamy .
PEDIATRIC DIABETES, 2014, 15 (06) :422-427
[4]
Trends in the Prevalence of Ketoacidosis at Diabetes Diagnosis: The SEARCH for Diabetes in Youth Study [J].
Dabelea, Dana ;
Rewers, Arleta ;
Stafford, Jeanette M. ;
Standiford, Debra A. ;
Lawrence, Jean M. ;
Saydah, Sharon ;
Imperatore, Giuseppina ;
D'Agostino, Ralph B., Jr. ;
Mayer-Davis, Elizabeth J. ;
Pihoker, Catherine .
PEDIATRICS, 2014, 133 (04) :E938-E945
[5]
Profound hypokalemia associated with severe diabetic ketoacidosis [J].
Davis, Shanlee M. ;
Maddux, Aline B. ;
Alonso, Guy T. ;
Okada, Carol R. ;
Mourani, Peter M. ;
Maahs, David M. .
PEDIATRIC DIABETES, 2016, 17 (01) :61-65
[6]
Subcutaneous use of a fast-acting insulin analog - An alternative treatment for pediatric patients with diabetic ketoacidosis [J].
Della Manna, T ;
Steinmetz, L ;
Campos, PR ;
Farhat, SCL ;
Schvartsman, C ;
Kuperman, H ;
Setian, N ;
Damiani, D .
DIABETES CARE, 2005, 28 (08) :1856-1861
[7]
The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children [J].
Edge, J. A. ;
Jakes, R. W. ;
Roy, Y. ;
Hawkins, M. ;
Winter, D. ;
Ford-Adams, M. E. ;
Murphy, N. P. ;
Bergomi, A. ;
Widmer, B. ;
Dunger, D. B. .
DIABETOLOGIA, 2006, 49 (09) :2002-2009
[8]
Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients [J].
Ersöz, HÖ ;
Ukinc, K ;
Köse, M ;
Erem, C ;
Gunduz, A ;
Hacihasanoglu, AB ;
Karti, SS .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (04) :429-433
[9]
DIABETIC KETOACIDOSIS - LOW-DOSE INSULIN THERAPY BY VARIOUS ROUTES [J].
FISHER, JN ;
SHAHSHAHANI, MN ;
KITABCHI, AE .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (05) :238-241
[10]
The rise of childhood type 1 diabetes in the 20th century [J].
Gale, EAM .
DIABETES, 2002, 51 (12) :3353-3361